APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism.

Giammanco, Antonina; Spina, Rossella; Cefalù, Angelo B; Averna, Maurizio

Giammanco, Antonina; Spina, Rossella; Cefalù, Angelo B; Averna, Maurizio.

Afiliação

Giammanco A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro" (PROMISE), University of Palermo, Palermo, Italy.
Spina R; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro" (PROMISE), University of Palermo, Palermo, Italy.
Cefalù AB; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro" (PROMISE), University of Palermo, Palermo, Italy.
Averna M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro" (PROMISE), University of Palermo, Palermo, Italy. maurizio.averna@unipa.it.

Curr Atheroscler Rep ; 25(3): 67-76, 2023 03.

Article em En | MEDLINE | ID: mdl-36689070

Assuntos

Doença da Artéria Coronariana; Hipertrigliceridemia; Humanos; Apolipoproteína C-III/metabolismo; Doença da Artéria Coronariana/complicações; Células Endoteliais/metabolismo; Hipertrigliceridemia/metabolismo; Metabolismo dos Lipídeos; Triglicerídeos/metabolismo

Palavras-chave

ApoC-III; Cardiovascular disease burden; Post prandial lipemia; Therapeutic target; Triglyceride-rich lipoproteins (TRLs)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Hipertrigliceridemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google